OPN mRNA expression increased the risk of recurrence with an OR = 2.50 (95% CI; 1.30–4.82) for which, when adjusted for tumor grade, the HER 2 status and other treatments had an OR = 3.62 (95% CI; 1.45–9.07). Here, SPP1 is linked to neoplasm.